Targeted therapies for bone sarcomas

gan Heymann, Dominique, Rédini, Françoise
Cyhoeddwyd 2013

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma

gan Redini, Françoise, Heymann, Dominique
Cyhoeddwyd yn Front Oncol (2015)

Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment

gan Verrecchia, Franck, Rédini, Françoise
Cyhoeddwyd yn Front Oncol (2018)

RANKL/RANK/OPG: key therapeutic target in bone oncology

gan Ando, Kosei, Mori, Kanji, Rédini, Françoise, Heymann, Dominique
Cyhoeddwyd 2008

TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment

gan Picarda, Gaëlle, Trichet, Valérie, Téletchéa, Stéphane, Heymann, Dominique, Rédini, Françoise
Cyhoeddwyd 2011

Mifamurtide for the treatment of nonmetastatic osteosarcoma

gan Ando, Kosei, Mori, Kanji, Corradini, Nadège, Redini, Françoise, Heymann, Dominique
Cyhoeddwyd 2011

SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression

gan Lézot, Frédéric, Corre, Isabelle, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck
Cyhoeddwyd yn Cells (2020)

The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem

gan Corre, Isabelle, Verrecchia, Franck, Crenn, Vincent, Redini, Francoise, Trichet, Valérie
Cyhoeddwyd yn Cells (2020)

Antagonistic Functions of Connexin 43 during the Development of Primary or Secondary Bone Tumors

gan Talbot, Julie, Dupuy, Maryne, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck
Cyhoeddwyd yn Biomolecules (2020)

New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?

gan Danieau, Geoffroy, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck, Brounais-Le Royer, Bénédicte
Cyhoeddwyd yn Int J Mol Sci (2019)

Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?

gan Morice, Sarah, Danieau, Geoffroy, Rédini, Françoise, Brounais-Le-Royer, Bénédicte, Verrecchia, Franck
Cyhoeddwyd yn Cancers (Basel) (2020)

Molecular Alterations Associated with Osteosarcoma Development

gan Ando, Kosei, Mori, Kanji, Verrecchia, Franck, Marc, Baud'huin, Rédini, Françoise, Heymann, Dominique
Cyhoeddwyd 2012

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma

gan Ando, Kosei, Heymann, Marie-Françoise, Stresing, Verena, Mori, Kanji, Rédini, Françoise, Heymann, Dominique
Cyhoeddwyd 2013

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases

gan Lamora, Audrey, Mullard, Mathilde, Amiaud, Jérôme, Brion, Régis, Heymann, Dominique, Redini, Françoise, Verrecchia, Franck
Cyhoeddwyd yn Oncotarget (2015)

TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression

gan Lamora, Audrey, Talbot, Julie, Mullard, Mathilde, Brounais-Le Royer, Benedicte, Redini, Françoise, Verrecchia, Franck
Cyhoeddwyd yn J Clin Med (2016)

A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis

gan Le Goff, Benoit, Soltner, Elise, Charrier, Céline, Maugars, Yves, Rédini, Françoise, Heymann, Dominique, Berthelot, Jean-Marie
Cyhoeddwyd 2009

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models

gan Gobin, Bérengère, Moriceau, Gatien, Ory, Benjamin, Charrier, Céline, Brion, Régis, Blanchard, Frederic, Redini, Françoise, Heymann, Dominique
Cyhoeddwyd 2014

L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer

gan Biteau, Kevin, Guiho, Romain, Chatelais, Mathias, Taurelle, Julien, Chesneau, Julie, Corradini, Nadège, Heymann, Dominique, Redini, Françoise
Cyhoeddwyd yn Am J Cancer Res (2016)

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma

gan Lamoureux, Francois, Baud'huin, Marc, Ory, Benjamin, Guiho, Romain, Zoubeidi, Amina, Gleave, Martin, Heymann, Dominique, Rédini, Françoise
Cyhoeddwyd 2014

Receptor Activator of Nuclear Factor κB Ligand (RANKL)/Osteoprotegerin (OPG) Ratio Is Increased in Severe Osteolysis

gan Grimaud, Eva, Soubigou, Luc, Couillaud, Séverine, Coipeau, Patrick, Moreau, Anne, Passuti, Norbert, Gouin, François, Redini, Françoise, Heymann, Dominique
Cyhoeddwyd 2003